Webdisclosure.com

SANOFI-AVENTIS (EPA:SAN)

10/07/2022 15:45

Press Release: Fitusiran prophylaxis reduced bleeds by 61% in people with hemophilia A or B, with or without inhibitors, compared to prior factor or bypassing agent prophylaxis

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

10/07/2022 15:45

Press Release: Pivotal data demonstrate once-weekly efanesoctocog alfa provides superior bleed protection compared to prior factor prophylaxis

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

04/07/2022 12:00

Sanofi Global Health launches nonprofit Impact® brand for 30 medicines in low-income countries

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

28/06/2022 07:30

Press Release: Xenpozyme® (olipudase alfa) approved by European Commission as first and only treatment for ASMD

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

28/06/2022 07:30

Press Release: Nexviadyme® (avalglucosidase alfa) approved by European Commission as a potential new standard of care for the treatment of Pompe Disease

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

27/06/2022 22:57

Sanofi: Information concerning the total number of voting rights and shares – May 2022

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

24/06/2022 07:32

Availability of the Q2 2022 Memorandum for modelling purposes

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

08/06/2022 11:21

Sanofi launches its first Digital Accelerator fueled by new talent and focused on growth

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

07/06/2022 22:45

Press Release: FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 months to 5 years with moderate-to-severe atopic dermatitis

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

02/06/2022 13:30

Press Release: Sanofi grants Regeneron worldwide exclusive license rights to Libtayo® (cemiplimab)

Voir tous les communiqués de SANOFI-AVENTIS

«
1
2
3
4
5
6
7
8
9
10